This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech Continues to Lead Market: Innovation and M&A

NEW YORK (TheStreet) - The big news of today was Actavis' (ACT) announcement o buy Forest Labs (FRX) for $25 billion. And this is much more than just another win for Carl Icahn, the second largest holder of Forest Labs, which has gotten a lot of focus in media outlets.

Remember, both Actavis and Forest Labs have benefited from merger activity. Actavis rose sharply after announcing the $8.5 billion acquisition of Warner Chilcott last year-- increasing exposure to dermatology and gastroenterology-- and allowing the company to relocate to Dublin, Ireland where the tax rate is significantly lower, a theme we have seen by a number of names including Perrigo (PRGO).

So is this financial engineering? Well, it is creating shareholder value-- and coming with higher stock prices. And that's what matters here.

It was correct for Jim Cramer to highlight Actavis as an acquisition winner in Get Rich Carefully, as they have done it again.  Forest Labs offers them double-digit earnings growth and synergies to boot. And growth is key in this group.

Must Read: Online Travel Agencies: Secular Winners

M&A in the group isn't the only thing that is propelling the group higher. We continue to get more approvals, including at Chelsea Therapeutics (CHTP) today... not to mention strong sales results from the likes of Regeneron (REGN), Gilead (GILD) and Biogen (BIIB).

When we think of innovation, biotech is the first sector to think of... not tech.

--Written by Nicole Urken in New York.

>Contact by Email.


Chart of I:DJI
DOW 16,912.29 +122.10 0.73%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,791.1520 +42.7910 0.90%

Nicole's Tweets

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs